Close Menu
  • Home
  • Finance News
  • Personal Finance
  • Investing
  • Cards
    • Credit Cards
    • Debit
  • Insurance
  • Loans
  • Mortgage
  • More
    • Save Money
    • Banking
    • Taxes
    • Crime
What's Hot

Two factors to consider when investing in ETFs

August 5, 2025

Trump’s immigration policy is pressuring remittances | PaymentsSource

August 5, 2025

Issuer comparison: Bank of America vs. Chase

August 5, 2025
Facebook X (Twitter) Instagram
Facebook X (Twitter) Instagram
Smart SpendingSmart Spending
Subscribe
  • Home
  • Finance News
  • Personal Finance
  • Investing
  • Cards
    • Credit Cards
    • Debit
  • Insurance
  • Loans
  • Mortgage
  • More
    • Save Money
    • Banking
    • Taxes
    • Crime
Smart SpendingSmart Spending
Home»Finance News»PLTR, HIMS, VRTX and more
Finance News

PLTR, HIMS, VRTX and more

August 5, 2025No Comments2 Mins Read
Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
PLTR, HIMS, VRTX and more
Share
Facebook Twitter LinkedIn Pinterest Email

Check out the companies making headlines in extended trading: Palantir — The defense technology stock advanced 4% after second-quarter earnings exceeded Wall Street’s expectations. Palantir said it reported adjusted earnings of 16 cents per share on $1 billion in revenue, while analysts polled by LSEG anticipated 14 cents in earnings per share and $940 million in revenue. Vertex Pharmaceuticals — The biotech stock sank 14% after second-quarter earnings topped estimates. Vertex posted adjusted earnings of $4.52 per share on revenue of $2.96 billion, while analysts surveyed by LSEG had penciled in $4.26 in earnings per share and $2.91 billion in revenue. Hims & Hers Health — Shares tumbled 12% after the telehealth company issued disappointing guidance. Hims sees third-quarter adjusted earnings before interest, taxes, depreciation and amortization ranging from $60 million to $70 million, while StreetAccount consensus estimates called for $77 million. Second-quarter results were mixed, with revenue missing expectations, while adjusted earnings narrowly beat. Syndax Pharmaceuticals — The biopharma stock slipped 3% after Syndax guided for a third-quarter research and development expense of between $95 million and $100 million, while analysts polled by FactSet had expected $65.8 million. However, the company posted second-quarter revenue that exceeded expectations, as well as a narrower-than-expected loss per share. Dorman Products — The vehicle parts supplier popped 7% after hiking its full-year earnings guidance to between $8.60 and $8.90 per share, excluding items, from a range of $7.55 to $7.85 a share. Dorman also issued better-than-expected top- and bottom-line results for the second quarter, per FactSet. V2X — Shares rose more than 2% after the aerospace and defense company’s second-quarter results beat Wall Street’s expectations. V2X posted adjusted earnings of 33 cents per share, while analysts polled by FactSet had penciled in 97 cents per share. The company’s revenue of $1.08 billion also beat the consensus estimate of $1.05 billion. Additionally, it raised its full-year earnings forecast. MercadoLibre — Shares dropped 4% after the Latin American e-commerce platform reported second-quarter earnings that missed expectations. MercadoLibre posted earnings of $10.31 per share, below the $11.93 per share estimated by analysts polled by FactSet. On the other hand, expected revenue of $6.79 billion topped the $6.67 billion consensus estimate. — CNBC’s Darla Mercado, Sean Conlon, Lisa Kailai Han and Sarah Min contributed reporting.

See also  What Trump’s Tariff About-Face Means To The U.S. Economy

Source link

HIMS PLTR VRTX
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
Previous ArticleFintech investment holds steady amid trade war
Next Article Top Mortgage Lenders in Nevada

Related Posts

Two factors to consider when investing in ETFs

August 5, 2025

What happens to student loan borrowers who stay in SAVE forbearance

August 4, 2025

Stocks making the biggest moves premarket: ON, W, SPOT, TSLA

August 4, 2025
Add A Comment
Leave A Reply Cancel Reply

Top Posts

CFPB takes aim at credit card issuers over ‘bait-and-switch’ rewards

December 19, 2024

What is an SBA disaster loan?

May 26, 2025

Stocks making the biggest moves after hours: MCD, STX, CSGP

October 22, 2024
Ads Banner

Subscribe to Updates

Subscribe to Get the Latest Financial Tips and Insights Delivered to Your Inbox!

Stay informed with our finance blog! Get expert insights, money management tips, investment strategies, and the latest financial news to help you make smart financial decisions.

We're social. Connect with us:

Facebook X (Twitter) Instagram YouTube
Top Insights

Two factors to consider when investing in ETFs

August 5, 2025

Trump’s immigration policy is pressuring remittances | PaymentsSource

August 5, 2025

Issuer comparison: Bank of America vs. Chase

August 5, 2025
Get Informed

Subscribe to Updates

Subscribe to Get the Latest Financial Tips and Insights Delivered to Your Inbox!

© 2025 Smartspending.ai - All rights reserved.
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.